Myxomatous Mitral Valve Disease in a German Shepherd Dog


4 / 3

Authors

  • Shruti Kachroo Department of Veterinary Medicine, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana – 141004, India
  • Asmita Narang Department of Veterinary Medicine, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana – 141004, India
  • Shabnam Sidhu Department of Veterinary Medicine, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana – 141004, India
  • Sushma Chhabra Department of Veterinary Medicine, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana – 141004, India
  • Neetu Saini Department of Veterinary Medicine, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana – 141004, India

https://doi.org/10.56093/ijvm.v46i1.178932

Keywords:

MMVD, German Shepherd, echocardiography, arrythmia

Abstract

A four-year-old male German Shepherd dog was presented to the Small Animal Clinics, GADVASU, with the primary complaint of exercise intolerance for the past 3-4 days and chronic weight loss. Physical examination revealed poor body condition and dull mentation, fever and tachycardia. Conjunctival mucous membranes and palpation of lymph nodes were normal. The animal was subjected to blood sampling, thoracic radiography, electrocardiography and echocardiography. Haemoglobin was 14.7g% and TLC was 13,900 cu mm, showing absolute neutrophilia. Thoracic radiography showed heart occupying 83% of chest in ventral-dorsal view, suggestive of cardiac enlargement. Electrocardiography revealed an extremely rapid rhythm with a heart rate of 300 beats per minute, indicating emergency condition. Echocardiography revealed left atrium and ventricle enlargement, along with mild flattening of mitral valve and mitral regurgitation. Values of Ao, LA and their ratio (LA/Ao) were 1.80, 4.99 and 2.72 respectively. Based on the findings, the case was diagnosed for Myxomatous Mitral Valve Disease. The dog was treated with digoxin 250mcg and diltiazem 45 mg twice a day for first two days to control arrythmia. Further treatment was continued with tab pimobendan and enalapril at the dose of 5mg twice a day.  The dog was telephonically reported to be stable after 14 days.

Downloads

Download data is not yet available.

References

Atkins, C. E., Bonagura, J. D., Ettinger, S. J., Fox, P. R., Gordon, S. G., Häggström, J., Hamlin, R. L., Keene, B. W., Luis-Fuentes, V., & Stepien, R. L. 2009. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. Journal of Veterinary Internal Medicine: 23(6): 1142–1150. https://doi.org/10.1111/j.1939-1676.2009.0392.x

Burchell, R. K., & Schoeman, J. P. 2014. Advances in the understanding of the pathogenesis, progression and diagnosis of myxomatous mitral valve disease in dogs. Journal of the South African Veterinary Association: 85(1): 1–5. https://doi.org/10.4102/jsava.v85i1.1101

Keene, B. W., Atkins, C. E., Bonagura, J. D., Fox, P. R., Häggström, J., Luis Fuentes, V., Oyama, M. A., Rush, J. E., Stepien, R. L., & Uechi, M. 2019. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. Journal of Veterinary Internal Medicine: 33(3): 1127–1140. https://doi.org/10.1111/jvim.15488

Hemoglobin, G., & Borgarelli, M. 2017. Review of diagnostic and therapeutic approach to canine myxomatous mitral valve disease. Veterinary Sciences: 4(4): 47. https://doi.org/10.3390/vetsci4040047

Olsen, L. H., Häggström, J., & Petersen, H. D. 2010. Acquired valvular heart disease. In: Ettinger, S. & Feldman, E. (eds.), Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat. Elsevier Saunders, St. Louis, MO: 1299–1319.

Downloads

Submitted

12-05-2026

Published

24-06-2026

How to Cite

Kachroo, S., Narang, A. ., Shabnam Sidhu, Chhabra, S. ., & Neetu Saini. (2026). Myxomatous Mitral Valve Disease in a German Shepherd Dog. Indian Journal of Veterinary Medicine, 46(1), 35-37. https://doi.org/10.56093/ijvm.v46i1.178932
Citation